Kemnay Advisory Services’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$269K Buy
292
+20
+7% +$20.3K 0.04% 26
2025
Q4
$292K Buy
+272
New +$260K 0.04% 26

Other funds holding LLY

Kemnay Advisory Services's LLY Position: Q1 2026 in Review

Kemnay Advisory Services increased its Eli Lilly (LLY) stake by 7.4% in Q1 2026, buying an estimated $20.3K and bringing the position to 292 shares worth $269K. The position accounts for 0.04% of the portfolio, ranked #26.

Kemnay Advisory Services first reported a position in LLY in Q4 2025 and has held it in 2 quarters since. The position peaked at $292K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Kemnay Advisory Services held 292 shares of Eli Lilly worth $269K as of Q1 2026.
  • Kemnay Advisory Services bought 20 Eli Lilly shares in Q1 2026, an estimated $20.3K.
  • Eli Lilly made up 0.04% of Kemnay Advisory Services's portfolio in Q1 2026, its #26 holding.
  • Kemnay Advisory Services first reported a position in Eli Lilly in Q4 2025 and has held it in 2 quarters since.
  • Kemnay Advisory Services's Eli Lilly position peaked at $292K in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Kemnay Advisory Services's 13F filing for Q1 2026, filed 15 May 2026.